GenMark Diagnostics Dismisses Patent Lawsuit Against Caliper Life Sciences
News Mar 11, 2011
GenMark Diagnostics has announced that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc. The suit sought Declaratory Relief that GenMark does not infringe U.S.
Patent No. 6,366,924 entitled “Distributed Database for Analytical Instruments”; U.S. Patent No. 6,399,025 entitled “Analytical System and Method”; U.S. Patent No. 6,495,104 entitled “Indicator Components for Microfluidic Systems” and that these patents are invalid.
Researchers have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.